Medical Director

About Vero Bioscience

Vero Bioscience is a predictive health company on a mission to end age-related chronic disease. Built on groundbreaking Stanford University research, Vero uses advanced proteomics and machine learning to measure organ and cellular health from a single blood draw. Vero’s OrganAge™ test is the entry point to Vero Compass™ – a biological intelligence system that translates complex biological signals into actionable insights that help clinicians and individuals intervene earlier and track meaningful improvement over time. Backed by leading scientific and clinical advisors, Vero is building the next era of predictive health to empower people to prevent disease and extend healthspan.

Vero is currently accessible through exclusive clinical research partnerships, with limited early access launching ahead of broad consumer availability in 2027. The company was founded by Paul Coletta, Tony Wyss-Coray, PhD, and Markus Okumus, backed by Khosla Ventures, and works with leading scientists, clinicians, research institutions, and health organizations to translate frontier aging science into useful products for predictive health.

The opportunity

At Vero, we bridge advanced science with compassionate, high-touch clinical oversight. We are seeking a forward-thinking physician leader to serve as our Medical Director—a dual-impact role designed to lead direct participant care while actively guiding the clinical logic behind our platform's clinical AI intelligence, research protocols, and product innovation more broadly.

The Medical Director occupies a high-impact position at the intersection of active clinical guidance and consumer healthtech innovation. This person will act as the core clinical leader, serving as Principal Investigator for clinical studies, collaborating on the development of protocols, interpreting novel proteomic and multi-omic data, and ensuring participant safety across active cohort studies.

Simultaneously, the Medical Director will collaborate directly with computational biologists, software engineers, and product managers to translate clinical insights into platform features, reporting tools, and clinical decision-support systems.

The Medical Director reports to Co-Founder and CEO Paul Coletta, and works with Tony Wyss-Coray, PhD (Co-Founder), clinical and scientific advisors, product, engineering, clinical partners, and research collaborators.

Role mandate

Lead the clinical function that makes Vero’s science safe, responsible, and useful for participants and clinicians. The Medical Director will oversee participant care and safety, guide the clinical interpretation of complex biological data, and help translate emerging science into responsible research protocols, clinical workflows, and product capabilities.

Core responsibilities

Direct participant experience and clinical oversight

• High-touch participant engagement: Serve as the primary clinical touchpoint for participants, interpreting complex multi-omic profiles—including plasma proteomics, routine blood panels, microbiome data, and functional metrics—and translating them into clear, responsible, and actionable guidance.
• Safety and protocol supervision: Oversee participant onboarding, health-history screening, baseline evaluations, and risk mitigation across clinical studies and product cohorts.
• Intervention guidance: Collaborate with participants to safely implement, monitor, and adjust evidence-based lifestyle and supplement protocols.
• Clinical interpretation: Translate intricate, high-dimensional molecular data into clear, actionable behavioral and therapeutic pathways.

Product development and clinical innovation

• Clinical decision-support development: Partner with our data science and engineering teams to annotate, evaluate, and refine AI-driven clinical decision-support systems and automated report generators.
• Feature and pipeline guidance: Direct the development of new clinical dashboards, participant-facing educational assets, and clinician workflows based on real-world participant interactions.
• Translational protocol design: Bridge academic findings in proteomics, immunology, and longevity science into standardized, scalable clinical operational protocols.
• Regulatory and IRB strategy: Help shape clinical protocols and amendments, IRB filings, safety-monitoring plans, and regulatory compliance frameworks.

First-year outcomes

• A clear clinical-oversight framework for participant onboarding, safety monitoring, risk mitigation, and escalation across Vero’s active studies and product cohorts.
• Consistent standards for interpreting and communicating complex proteomic and multi-omic results to participants and clinicians.
• Clinically sound protocols and workflows that translate emerging research into responsible, scalable participant experiences.
• A structured clinical approach to the development and evaluation of decision-support systems, automated reports, dashboards, and educational assets.
• Strong coordination across clinical, scientific, data, engineering, product, regulatory, and research partners.

Ideal background

• Clinical experience. At least seven years of direct patient-care experience following residency, with experience in preventive, longitudinal, or complex-care settings preferred.
• Startup and technology orientation. Interest in working within fast-paced healthtech, digital-health, or clinical-research environments, and comfort providing structured feedback to computational, engineering, and product teams.
• Communicator and educator. Exceptional bedside manner with a proven track record of translating complex biological risk data into accessible patient education.
• Scientific depth and multi-omics experience preferred. Strong foundational understanding of biological aging mechanisms, systems biology, and translational clinical research methodology. Experience interpreting complex multi-omic datasets, including plasma proteomics and genomics, is strongly preferred, as is prior research experience and peer-reviewed publication in a relevant field.

Required qualifications

• MD or DO with an active, unrestricted US medical license and board certification in Internal Medicine, Family Medicine, Preventive Medicine, or another relevant specialty with Functional Medicine or Integrative/Precision Medicine training.
• Seven years of direct patient-care experience following residency.
• Experience with clinical research, including protocol development, participant safety, and IRB processes.
• Demonstrated ability to work effectively with scientific, computational, engineering, and product teams.

Leadership profile

• Trusted clinician: Brings sound clinical judgment, prioritizes participant safety, and inspires confidence in participants, clinicians, and partners.
• Clear communicator and educator: Translates intimidating or complex biological risk data into accessible guidance without overstating what the evidence shows.
• Scientifically rigorous: Evaluates emerging evidence carefully and distinguishes promising findings from established clinical knowledge.
• Participant-centered: Combines compassion and high-touch engagement with consistent, responsible clinical oversight.
• Collaborative and low-ego: Works effectively with scientists, engineers, product leaders, clinical partners, and advisors, and welcomes challenge from other disciplines.
• Entrepreneurial: Operates well in a fast-paced environment, gives practical guidance, and helps translate emerging science into scalable clinical workflows.

What success looks like

Vero’s clinical function becomes both trusted and scalable. Participants receive thoughtful, high-touch clinical oversight; studies and product cohorts operate with clear safety standards; and complex biological findings are interpreted responsibly and communicated clearly. Clinical insights strengthen Vero’s protocols, reports, workflows, and decision-support capabilities, while the company’s clinical guidance and claims remain aligned with the evidence.

Why join Vero Bioscience

This is an opportunity to help define a new category of predictive health. Vero sits at the intersection of frontier aging biology, proteomics, machine learning, clinical translation, and consumer product design.

• Shape the future of medicine: Be at the forefront of translating dynamic plasma proteomics into everyday clinical utility.
• High-impact dual role: Direct the care of participants while building technology that scales to consumers.
• Collaborative culture: Work alongside world-class scientists, engineers, and clinical advisors from top institutions.
• Compensation: Competitive compensation and meaningful early-stage equity ownership.